The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 39, Issue 10, 1996, Pages 1693-1702

  Isomäki, Pia ^a   Luukkainen, Reijo ^b   Toivanen, Paavo ^a   Punnonen, Juha ^a,c  

^a TURKU UNIVERSITY   (Finland)

^b Satalinnan Sairaala   (Finland)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13;

ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PLASMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM;

EID: 0029740959     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391012     Document Type: Article

References (54)

1. Miyasaka N, Sato K, Goto M, Sasano M, Natsuyama M, Inoue K, Nishioka K: Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: possible involvement in joint destruction. Arthritis Rheum 31:480-486, 1988
2. Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, Kishimoto T: Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18:1797-1801, 1988
3. Katsikis PD, Chu C-Q, Brennan FM, Maini RN, Feldmann M: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179:1517-1527, 1994
4. Isomäki P, Luukkainen R, Saario R, Toivanen P, Punnonen J: Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum 39:386-395, 1996
5. Chu CQ, Field M, Feldmann M, Maini RN: Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 34:1125-1132, 1991
6. Haworth C, Brennan FM, Chantry D, Turner M, Maini RN, Feldmann M: Expression of granulocyte-macrophage colonystimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α. Eur J Immunol 21:2575-2579, 1991
7. Buchan G, Barrett K, Fujita T, Taniguchi T, Maini R, Feldmann M: Detection of activated T cell products in the rheumatoid joint using cDNA probes to interleukin-2 (IL-2), IL-2 receptor and IFNγ. Clin Exp Immunol 71:295-301, 1988
8. Chen E, Keystone EC, Fish EN: Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 36:901-910, 1993
9. Simon AK, Seipelt E, Sieper J: Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A 91:8562-8566, 1994
10. Miossec P, Naviliat M, Dupuy d'Angeac A, Sany J, Banchereau J: Low levels of interleukin-4 and high levels of transforming growth factor β in rheumatoid synovitis. Arthritis Rheum 33:1180-1187, 1990
11. Yanni G, Whelan A, Feighery C, Quinlain W, Symons J, Duff G, Bresnihan B: Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration. Clin Exp Immunol 93:387-395, 1993
12. Cush JJ, Lipsky PE: Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 31:1230-1238, 1988
13. Hemler ME, Glass D, Coblyn JS, Jacobson JG: Very late activation antigens on rheumatoid synovial fluid T lymphocytes. J Clin Invest 78:696-704, 1986
14. Maini RN, Chu CQ, Feldmann M: Aetiopathogenesis of rheumatoid arthritis. In, Mechanisms and Models in Rheumatoid Arthritis. Edited by B Henderson, JCW Edwards, ER Pettipher. London, Academic Press Limited, 1995
15. Panayi GS, Lanchbury JS, Kingsley GH: The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35:729-735, 1992
16. Mima T, Saeki Y, Ohshima S, Nishimoto N, Matsushita M, Shimizu M, Kobayashi Y, Nomura T, Kishimoto T: Transfer of rheumatoid arthritis into severe combined immunodeficient mice. J Clin Invest 96:1746-1758, 1995
17. Mosmann TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989
18. Cohen SBA, Katsikis PD, Chu C-Q, Thomssen H, Webb LMC, Maini RN, Londei M, Feldmann M: High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum 38:946-952, 1995
19. Miltenburg AMM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC: T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 35:603-610, 1992
20. Liblau RS, Singer SM, McDevitt HO: Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 34:34-38, 1995
21. Lee F, Yokota T, Otsuka T, Meyerson P, Villaret D, Coffman R, Mosmann T, Rennick D, Roehm N, Smith C, Zlotnik A, Arai K-I: Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. Proc Natl Acad Sci U S A 83:2061-2065, 1986
22. Noma Y, Sideras P, Naito T, Bergstedt-Lindquist S, Azuma C, Severinson E, Tanabe T, Kinashi T, Matsuda F, Yaoita Y, Honjo T: Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter. Nature 319:640-646, 1986
23. Te Velde AA, Huijbens RJF, Heije C, de Vries JE, Figdor CG: Interleukin-4 inhibits secretion of interleukin-1β, tumor necrosis factor α and interleukin-6 by human monocytes. Blood 76:1392-1397, 1990
24. De Waal Malefyt R, Figdor CE, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE: Effects of IL-13 on the phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol 151:6370-6381, 1993
25. Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J: Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 35:874-883, 1992
26. Miossec P, Chomarat P, Dechanet J, Moreau J-F, Roux J-P, Delmas P, Banchereau J: Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum 37:1715-1722, 1994
27. Dechanet J, Briolay J, Rissoan M-C, Chomarat P, Galizzi J-P, Banchereau J, Miossec P: IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J Immunol 151:4908-4917, 1993
28. Allen JB, Wong HL, Costa GL, Bienkowski MJ, Wahl SM: Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J Immunol 151:4344-4351, 1993
29. Minty A, Chalon P, Derocq J-M, Dumont X, Guillemot J-C, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362:248-250, 1993
30. McKenzie ANJ, Culpepper JA, de Waal Malefyt R, Briere F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BG, Menon S, de Vries JE, Banchereau J, Zurawski G: Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci U S A 90:3735-3739, 1993
31. Zurawski G, de Vries JE: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15:19-26, 1994
32. Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE: Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A 90:3730-3734, 1993
33. Punnonen J, de Vries JE: IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. J Immunol 152:1094-1102, 1994
34. Cash E, Minty A, Ferrara P, Caput D, Fradelizi D, Rott O: Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol 153:4258-4267, 1994
35. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
36. De Waal Malefyt R, Haanen J, Spits H, Roncarolo M-G, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915-924, 1991
37. Chretien I, van Kimmenade A, Pearce M, Banchereau J, Abrams JS: Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin-4. J Immunol Methods 117:67-73, 1989
38. De Waal Malefyt R, Abrams JS, Zurawski SM, Lecron J-C, Mohan-Peterson S, Sanjanwala B, Bennett B, Silver J, de Vries JE, Yssel H: Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol 7:1405-1416, 1995
39. Abrams JS, Roncarolo M-G, Yssel H, Andersson U, Gleich GJ, Silver JE: Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 127:5-24, 1992
40. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979
41. Krug MS, Berger SI: First-strand cDNA synthesis primed with oligo(dT). Methods Enzymol 152:316-325, 1987
42. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991
43. Hart PH, Ahern MJ, Jones CA, Jones KL, Smith MD, Finlay-Jones JJ: Synovial fluid macrophages and blood monocytes differ in their responses to IL-4. J Immunol 151:3370-3380, 1993
44. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ: Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin Exp Immunol 99:331-337, 1995
45. Spits H, Yssel H, Takebe Y, Arai N, Yokota T, Lee F, Arai K-I, Banchereau J, de Vries JE: Recombinant interleukin 4 promotes the growth of human T cells. J Immunol 139:1142-1147, 1987
46. Zurawski SM, Vega F, Huyghe B, Zurawski G: Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 12: 2663-2670, 1993
47. Köhler I, Alliger P, Minty A, Caput D, Ferrara P, Höll-Neugebauer B, Rank G, Rieber EP: Human interleukin-13 activates the interleukin-4-dependent transcription factor NF-IL-4 sharing a DNA binding motif with an interferon-γ-induced nuclear binding factor. FEBS Lett 345:187-192, 1994
48. Dayer J-M, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA: Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 77:645-648, 1986
49. Dayer J-M, Beutler B, Cerami A: Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163-2168, 1985
50. Campbell IK, Piccoli DS, Roberts MJ, Muirden KD, Hamilton JA: Effects of tumor necrosis factor α and β on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis Rheum 33:542-552, 1990
51. Hom JT, Bendele AM, Carlson DG: In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. J Immunol 141:834-841, 1988
52. Keffer J, Lesley P, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G: Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025-4031, 1991
53. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110, 1994
54. De Vries JE, Carballido JM, Sornasse T, Yssel H: Antagonizing the differentiation and functions of human Th2 cells. Curr Opin Immunol 7:771-778, 1995